| 2007 JASN IMPACT FACTOR 7.111 | HOME AUTHOR INFO EDITORIAL BOARD SUBSCRIBE FEEDBACK ALERTS HELP | |||
| CURRENT ISSUE | ARCHIVES | JASN Express | ONLINE SUBMISSION | |
Journal of the American Society of Nephrology, Vol 7, 218-224, Copyright © 1996 by American Society of Nephrology
REGULAR ARTICLES |
N Topley, D Kaur, MM Petersen, A Jorres, JD Williams, D Faict and CJ Holmes
Institute of Nephrology, University of Wales College of Medicine, Cardiff, United Kingdom.
The inclusion of bicarbonate in the formulation of peritoneal dialysis solutions may avoid the in vitro impairment of certain cell functions seen with acidic lactate-based fluids. The supranormal physiological levels of HCO3- and PCO2 inherent in such formulations may, however, not be biocompatible. This study compared the in vitro biocompatibility of a pH 5.2 lactate-based formulation with formulations containing either 40 mM lactate at pH 7.4, 38 mM HCO3- at pH 6.8 (PCO2 at approximately 240 mm Hg) or 7.4 (PCO2 at approximately 60 mm Hg), and 25 mM HCO3- plus 15 mM lactate at pH 6.8 (PCO2 at approximately 160 mm Hg) or 7.4 (PCO2 at approximately 40 mm Hg). Significant release of lactate dehydrogenase or decreases in ATP content by human peritoneal mesothelial cells (HPMC) and human peripheral polymorphonuclear leukocytes (PMN) after a 30-min exposure to each test solution was only seen with the pH 5.2 lactate-based fluid. The ATP content of HPMC exposed to this fluid returned to control levels after 30 min of recovery in M199 control medium but showed a trend toward decreasing ATP content at 240 min. Similarly, interleukin (IL)-1 beta-induced IL-6 synthesis by HPMC was also only significantly reduced by the pH 5.2 lactate solution. PMN chemiluminescence was unaffected by 30-min exposure to all test solutions except for the pH 5.2 lactate formulation. Staphylococcus epidermidis phagocytosis was reduced to between 46 to 57% of control with all test solutions except the pH 5.2 lactate solution, which further suppressed the chemiluminescence response to 17% of control. These data suggest that short exposure to supranormal physiological levels of HCO3- and PCO2 does not impair HPMC or PMN viability and function. Furthermore, neutral pH lactate- containing solutions show equivalent biocompatibility to bicarbonate- based ones.
This article has been cited by other articles:
![]() |
A. G. A. Welten, M. Zareie, J. van den Born, P. M. ter Wee, C. G. Schalkwijk, B. A. J. Driesprong, F. P. J. Mul, P. L. Hordijk, R. H. J. Beelen, and L. H. P. Hekking In vitro and in vivo models for peritonitis demonstrate unchanged neutrophil migration after exposure to dialysis fluids Nephrol. Dial. Transplant., April 1, 2004; 19(4): 831 - 839. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Jones, C. J. Holmes, R. K. Mackenzie, R. Stead, G. A. Coles, J. D. Williams, D. Faict, and N. Topley Continuous Dialysis with Bicarbonate/Lactate-Buffered Peritoneal Dialysis Fluids Results in a Long-Term Improvement in Ex Vivo Peritoneal Macrophage Function J. Am. Soc. Nephrol., January 1, 2002; 13(90001): S97 - 103. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. H. P. Hekking, M. Zareie, B. A. J. Driesprong, D. Faict, A. G. A. Welten, I. de Greeuw, I. L. Schadee-Eestermans, C. E. G. Havenith, J. van den Born, P. M. Ter Wee, et al. Better Preservation of Peritoneal Morphologic Features and Defense in Rats after Long-Term Exposure to a Bicarbonate/Lactate-Buffered Solution J. Am. Soc. Nephrol., December 1, 2001; 12(12): 2775 - 2786. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Tuncer, M. Sarikaya, T. Sezer, S. Ozcan, G. Suleymanlar, G. Yakupoglu, and F. F. Ersoy Chemical peritonitis associated with high dialysate acetaldehyde concentrations Nephrol. Dial. Transplant., December 1, 2000; 15(12): 2037 - 2040. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. WITOWSKI, K. KORYBALSKA, J. WISNIEWSKA, A. BREBOROWICZ, G. M. GAHL, U. FREI, J. PASSLICK-DEETJEN, and A. JORRES Effect of Glucose Degradation Products on Human Peritoneal Mesothelial Cell Function J. Am. Soc. Nephrol., April 1, 2000; 11(4): 729 - 739. [Abstract] [Full Text] [PDF] |
||||
|
HOME
CURRENT ISSUE
ARCHIVES
JASN Express
ONLINE SUBMISSION
AUTHOR INFO
EDITORIAL BOARD SUBSCRIBE FEEDBACK ALERTS HELP |
Copyright © 2008 by the American Society of Nephrology. Online ISSN: 1533-3450 Print ISSN: 1046-6673